Back to Top
Go Back
Journal Photo for Clinical & Translational Immunology
Peer reviewed only Open Access

Clinical & Translational Immunology (CTI)

Publisher : John Wiley & Sons Inc
Nursing cell biology Immunology
e-ISSN 2050-0068
Issue Frequency Monthly
Impact Factor 5.8
Est. Year 2012
Mobile 0395866095
Country Australia
Language English
APC YES
Impact Factor Assignee Google Scholar
Email cti.office@unimelb.edu.au

Journal Descriptions

Clinical & Translational Immunology seeks to cover basic, translational and clinical studies in all aspects of human immunology, including experimental models specific to human diseases. Topics of particular interest within the journal’s scope include, but are not limited to, those listed below: -cutting edge approaches including in vivo models of human disease that shed light on the mechanisms of immunity -clinical studies with relevance to autoimmunity transplantation and tumor immunotherapy -cutting edge immunoassays for monitoring clinical trials/patient responses -infection and immunity - correlates of protection -immunotherapies in relation to autoimmunity, primary and secondary immunodeficiencies, --complement disorders and allergies -pathogenesis and correlates of protection for autoimmune and endocrine disorders, infectious --disease, malignancy and transplantation

Clinical & Translational Immunology (CTI) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Nursing, cell biology, Immunology, Allergy, Microbiology , Online , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2050-0068, Established: 2012, Impact Factor: 5.8
  • Does Not Provide Crossref DOI
  • Indexed in: Scopus, DOAJ, PubMed

  • Not indexed in WoS, UGC CARE

Indexing